Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pimecrolimus for Cetuximab-induced Rash Prevention
NCT01692626Phase 2Terminated
- Sponsor
- West Virginia University
- Start
- Feb 2012
- Primary completion
- Apr 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of pimecrolimus, sponsored by West Virginia University. Started Feb 2012; status: terminated.
02
Drugs
pimecrolimus
Beyond the preview
Go deeper on NCT01692626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01692626.